Dinaciclib

DESCRIPTION

A pan-CDK inhibitor (IC50s = 3, 1, 1, and 4 nM for CDK1, CDK2, CDK5, and CDK9, respectively) that inhibits DNA synthesis in A2780 ovarian cancer cells (IC50 = 4 nM); 5 mg/kg prevents tumor growth by 50% in an A2780 ovarian carcinoma mouse xenograft model; active against a broad spectrum of human tumor cell lines in vitro (IC50s = 7-17 nM)

DETAILS

Inchi: InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1
Purity: ≥98%
Raptas: Product Type|Biochemicals|Kinase Inhibitors|CDKs||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Cycle||Research Area|Cancer|Cell Signaling
Smiles: OCC[C@H]1N(C2=NC3=C(CC)C=NN3C(NCC4=CC=C[N+]([O-])=C4)=C2)CCCC1
Inchikey: PIMQWRZWLQKKBJ-SFHVURJKSA-N
Cas Number: 779353-01-4
Formulation: A crystalline solid
Storage Temp: -20
Shipping Temp: -20
Formula Markup: C21H28N6O2
Formula Weight: 396.5
Shelf Life Days: 1460